Neuropsychiatric Disease and Treatment · 2013 · 17 citations · 14 references
MedicinePharmacotherapyPsychiatryClinical PharmacologyPsychiatric PharmacotherapyPsychopharmacologyHypnotic PharmacotherapyHypnotic TherapyParasomniasSleep Disorder PharmacotherapySleep HealthSleep-wake DisordersAntidepressants For Sleep DisordersComparative Efficacy Of HypnoticsHypnotic MedicationsParasomnia PharmacotherapySleep Disorder Medications
OBJECTIVE: Complex sleep behaviors (CSBs) are classified as "parasomnias" in the International Classifcation of Sleep Disorders, Second Edition (ICSD-2). To realize the potential danger after taking two short-acting Z-hypnosedative drugs, we estimated the incidence of CSBs in nonpsychotic patients in Taiwan. METHODS: Subjects (N = 1,220) using zolpidem or zopiclone were enrolled from the psychiatric outpatient clinics of a medical center in Taiwan over a 16-month period in 2006-2007. Subjects with zolpidem (N = 1,132) and subjects with zopiclone (N = 88) were analyzed. All subjects completed a questionnaire that included demographic data and complex sleep behaviors after taking hypnotics. RESULTS: Among zolpidem and zopiclone users, 3.28% of patients reported incidents of somnambulism or amnesic sleep-related behavior problems. The incidence of CSBs with zolpidem and zopiclone were 3.27%, and 3.41%, respectively, which was signifcantly lower than other studies in Taiwan. CONCLUSION: These results serve as a reminder for clinicians to make inquiries regarding any unusual performance of parasomnic activities when prescribing zolpidem or zopiclone.
14
Nonbenzodiazepine Sleep Medication Use and Hip Fractures in Nursing Home Residents
Sarah D. Berry, Yoojin Lee, Shubing Cai et al. · JAMA Internal Medicine · 2013 · 142 citations · Full text